Jerash Holdings Reports Fiscal 2025 Third Quarter Financial Results — Neutral

JRSH   Accesswire — February 11, 2025

FAIRFIELD, NJ / ACCESS Newswire / February 11, 2025 / Jerash Holdings (US), Inc. ("Jerash" or the "Company") (NASDAQ:JRSH), which manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands, today announced financial results for its fiscal 2025 third quarter, ended December 31, 2024. "While revenue increased by nearly 30 percent for the fiscal third quarter, results were lower than originally anticipated," Sam Choi, Jerash's chairman and chief executive officer, said.

image for news Jerash Holdings Reports Fiscal 2025 Third Quarter Financial Results

PHILADELPHIA, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that updated clinical data on resecabtagene autoleucel (rese-cel, formerly referred to as CABA-201) will be featured in presentations at the 2025 American Association for the Advancement of Science Annual Meeting, which is being held at the Hynes Convention Center in Boston, MA from February 13-15, 2025, and the 5th International Conference on Lymphocyte Engineering, which is being held at the Holiday Inn Munich – …

image for news Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February

Groundbreaking System Successfully Operates From -57°F to 131°F, Eliminates Defrost Cycles, and Paves the Way for a New Era in Clean-Energy Efficiency West Seneca, New York, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S. based manufacturer and innovator of hybrid and clean energy solutions for the light truck, overlanding, and global consumer goods sectors, today announced that its wholly owned subsidiary, Terravis Energy, a Colorado corporation (“TVE”), has achieved a major industry milestone with the unveiling of the revolutionary AetherLux™ heat pump system.

image for news Worksport Subsidiary Terravis Energy Unveils Revolutionary Heat Pump, Eliminating Defrost Cycles & Shattering Performance Standards; AetherLux™

Groundbreaking System Successfully Operates From -57°F to 131°F, Eliminates Defrost Cycles, and Paves the Way for a New Era in Clean-Energy Efficiency West Seneca, New York--(Newsfile Corp. - February 11, 2025) - Worksport Ltd. (NASDAQ: WKSP) ("Worksport" or the "Company"), a U.S. based manufacturer and innovator of hybrid and clean energy solutions for the light truck, overlanding, and global consumer goods sectors, today announced that its wholly owned subsidiary, Terravis Energy, a Colorado corporation ("TVE"), has achieved a major industry milestone with the unveiling of the revolutionary AetherLux™ heat pump system.

image for news Worksport Subsidiary Terravis Energy Unveils Revolutionary Heat Pump, Eliminating Defrost Cycles & Shattering Performance Standards; AetherLux(TM)

Recurring Income: 2 Golden Opportunities At Multi-Year Lows — Positive

PEP  REXR   Seeking Alpha — February 11, 2025

It's a market for stocks rather than the stock market, and patient value investors are rewarded. In this article, I highlight 2 stocks that are trading way below their historical valuations, while providing well above-average yields. Both stocks carry moat-worthy business models and provide great entry points at present.

image for news Recurring Income: 2 Golden Opportunities At Multi-Year Lows

The 'Trump Factor' In Action: Why I'm Bullish On Alcoa — Positive

AA   Seeking Alpha — February 11, 2025

Alcoa's vertical integration and strong aluminum demand outside China position it well amid tariffs, supply chain shifts, and economic growth trends. Tariffs could disrupt operations, but Alcoa's flexibility and improved balance sheet offer resilience and potential for significant upside. Valuation is attractive, with potential for over 30% stock price upside if economic growth accelerates and tariff risks are mitigated.

image for news The 'Trump Factor' In Action: Why I'm Bullish On Alcoa

Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy — Neutral

LEXX   TheNewswire — February 11, 2025

Additions broaden DehydraTECH patent suite for Epilepsy Kelowna, British Columbia – TheNewswire - February 11, 2025 – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce that we have been granted two new patents from the United States Patent and Trademark Office for the use of DehydraTECH™ enhanced processing technology related to the treatment of epilepsy.

image for news Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy

HAMPTON, N.H. , Feb. 11, 2025 /PRNewswire/ -- Planet Fitness, Inc. (NYSE: PLNT) (the "Company"), today announced that the Company will report results for its fourth quarter ended December 31, 2024, before the market opens on Tuesday, February 25, 2025.

image for news PLANET FITNESS, INC. TO REPORT FOURTH QUARTER 2024 RESULTS ON FEBRUARY 25, 2025

VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, announces that its subsidiary ZenaDrone has commenced work towards a Green UAS (Unmanned Aerial System) certification for its IQ Square drone for applications including land survey, bridge inspections and other infrastructure inspections for use by US Defense agencies. The ZenaDrone team has commenced a review and assessment of its cybersecurity practices, standards compliance, product security, and supply chain documentation to prepare for …

image for news ZenaTech's ZenaDrone Subsidiary Initiates Process for Green UAS Certification for IQ Square Drone for Land Survey, Bridge Inspections, and Other US Defense Applications

AUSTIN, Texas, Feb. 11, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries.

image for news IBN Announces Latest Episode of The Bell2Bell Podcast featuring Richard Lu, CEO of SolarBank Corporation

PITTSBURGH , Feb. 11, 2025 /PRNewswire/ -- DICK'S Sporting Goods, Inc. (NYSE: DKS) will announce results for the fourth quarter and full year 2024 before the market opens on Tuesday, March 11 th. A conference call to discuss the results will be held that day at 8:00 a.m.

image for news DICK'S Sporting Goods Fourth Quarter Results Call Scheduled for March 11th

Leveraging KYLE's 4M Monthly Spotify Listeners, 6+M Social Media Followers Drop Powered by Laylo LOS ANGELES, Feb. 11, 2025 (GLOBE NEWSWIRE) -- LiveOne, Inc. (NASDAQ: LVO), a leading creator-first platform, proudly announces the launch of SMYLE Coffee, a collaboration with multi-platinum rapper and actor KYLE. The new coffee launched last Friday with a limited quantity of the product's first run and has already sold out.

image for news LiveOne's (NASDAQ: LVO) SMYLE Coffee Sells Out in Record Time: Strong Start to Its Entry into the $100B Coffee Market

Insmed To Present at March 2025 Investor Conferences — Neutral

INSM   PRNewsWire — February 11, 2025

BRIDGEWATER, N.J. , Feb. 11, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences: 45th Annual TD Cowen Healthcare Conference in Boston, on Monday, March 3, 2025, at 9:10 a.m.

image for news Insmed To Present at March 2025 Investor Conferences

ATLANTA , Feb. 11, 2025 /PRNewswire/ -- The Home Depot®, the world's largest home improvement retailer, announced today that it will hold its Fourth Quarter & Fiscal Year Earnings Conference Call on Tuesday, February 25, at 9 a.m. ET. A webcast will be available by logging onto http://ir.homedepot.com/events-and-presentations and selecting the Fourth Quarter Earnings Conference Call icon.

image for news The Home Depot to Host Fourth Quarter & Fiscal Year Earnings Conference Call on February 25

111, Inc. Regains Compliance with NASDAQ Requirement — Neutral

YI   PRNewsWire — February 11, 2025

SHANGHAI , Feb. 11, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, announced today that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") on February 10, 2025, confirming that Nasdaq has determined that for the last ten consecutive business days, from January 24, 2025 to February 7, 2025, the closing bid price of the Company's American Depositary Shares has been at $1.00 per share or greater. Accordingly, the Company has …

image for news 111, Inc. Regains Compliance with NASDAQ Requirement

New partnership underscores Globe Life and NMOHMF's shared commitment to those who have made the ultimate sacrifice MCKINNEY, Texas , Feb. 11, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) a Texas-based life insurance company, is pledging $2 million to the National Medal of Honor Museum Foundation (NMOHMF) ahead of the National Medal of Honor Museum's Grand Opening in Arlington, Texas, this coming spring. In recognition of this founding donation, the stage at the Museum's Neel Kearby Theater will bear the Globe Life name.

image for news Globe Life Pledges $2 Million to the National Medal of Honor Museum Foundation

ONCOR TO RELEASE 2024 RESULTS FEBRUARY 25 — Neutral

SRE   PRNewsWire — February 11, 2025

DALLAS , Feb. 11, 2025 /PRNewswire/ -- Oncor Electric Delivery Company LLC ("Oncor") plans to release its fourth quarter and year end 2024 results on February 25, prior to Sempra's (NYSE: SRE) (BMV: SRE) fourth quarter and year end 2024 results conference call. Oncor's earnings release will be available on Oncor's website, oncor.com.

image for news ONCOR TO RELEASE 2024 RESULTS FEBRUARY 25

100% of acute myeloid leukemia (AML) patients across both original and expansion cohorts remain in complete remission (CR), with a median follow-up of 20.1 months AML patients treated demonstrated one-year progression-free survival (PFS) and overall survival (OS), exceeding real-world control groups Patients treated with INB-100 demonstrating prolonged and durable remissions supported by gamma-delta T cell persistence beyond one year Company to host conference call at 8:30am EST today. Use this link to participate or access the listen-only version of the webcast here NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative …

image for news IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients

ISELIN, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, is pleased to announce the addition of Bill Fink as Executive Vice President, Chief Lending Officer, leading the commercial bank and the commercial lending growth strategy.

image for news Provident Bank Strengthens Executive Leadership Team, Welcoming Chief Lending Officer to Advance Commercial Banking and Lending Strategy

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences — Neutral

PMVP   GlobeNewsWire — February 11, 2025

PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Officer and Deepika Jalota, Pharm. D., Chief Development Officer, will participate at the following investor conferences. Management will also participate in one-on-one investor meetings.

image for news PMV Pharmaceuticals to Participate at Upcoming Investor Conferences